Medical Literature Monitoring and Entering Negative Reaction Reports — Pepgra.com
In Brief A novel process where European Medical Agency offers a new service. The service is focused around medical literature monitoring . This service is also a vital step to ensure that there is no duplication of negative reaction reports. This service came into effect from 1st September, 2015. Service Insights The European Medicines Agency (EMA) on 12th May, 2015 presented a politician intimation of medical literature monitoring service and also proclaimed that adverse reaction reports would be not be required to be entered within the EudraVigilance. the whole thing came into effect from 1st September, 2015 onwards. Following the announcement, the EMA has published an inventory of active substances and also provided a regard to the journals which will encompass this novel service. Initially, the service was poised to be initiated by taking around a restricted number (50 active molecules) of active substances from 1st July, 2015 and was alleged to be ...